These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 22679202)
1. For richer, for poorer, in sickness and in health: the entanglement of science and marketing. Smith GP Aust N Z J Psychiatry; 2012 Jun; 46(6):498-500. PubMed ID: 22679202 [No Abstract] [Full Text] [Related]
2. Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations. Rosenbaum L N Engl J Med; 2015 May; 372(19):1860-4. PubMed ID: 25946288 [No Abstract] [Full Text] [Related]
3. Key opinion leaders in psychiatry: a conflicted pathway to career advancement. Jureidini J Aust N Z J Psychiatry; 2012 Jun; 46(6):495-7. PubMed ID: 22679201 [No Abstract] [Full Text] [Related]
4. 'Interests' in medicine and the inadequacy of disclosure. Kerridge I Aust N Z J Psychiatry; 2012 Jun; 46(6):501-3. PubMed ID: 22679203 [No Abstract] [Full Text] [Related]
5. Conflicts of Interest. Roper N N Engl J Med; 2015 Aug; 373(8):778. PubMed ID: 26287863 [No Abstract] [Full Text] [Related]
7. Conflicts of Interest. Strandberg TE N Engl J Med; 2015 Aug; 373(8):779. PubMed ID: 26287865 [No Abstract] [Full Text] [Related]
8. Conflicts of Interest. Abramson J; Redberg R N Engl J Med; 2015 Aug; 373(8):778. PubMed ID: 26287862 [No Abstract] [Full Text] [Related]
9. Conflicts of Interest. Rosenbaum L N Engl J Med; 2015 Aug; 373(8):779-80. PubMed ID: 26287861 [No Abstract] [Full Text] [Related]
10. Yes, industry influence is excessive. Shah AA; Finucane TE Int Psychogeriatr; 2007 Dec; 19(6):1004-10; discussion 1014-20. PubMed ID: 17711608 [No Abstract] [Full Text] [Related]
11. Small gifts, conflicts of interest, and the zero-tolerance threshold in medicine. Krimsky S Am J Bioeth; 2003; 3(3):50-2. PubMed ID: 14594492 [No Abstract] [Full Text] [Related]
12. Research dishonesty and conflict of interest. Frizelle F N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259 [No Abstract] [Full Text] [Related]
13. US Senate committee investigates conflicts of interest in industry funded medical education. Tanne JH BMJ; 2009 Aug; 339():b3139. PubMed ID: 19654162 [No Abstract] [Full Text] [Related]
14. Australian regulator insists on greater transparency of industry payments to doctors. Coopes A BMJ; 2014 Oct; 349():g6335. PubMed ID: 25331811 [No Abstract] [Full Text] [Related]
15. Money for drugs: should physicians be paid for pharmaceutical development and clinical investigations? Van Way C; Bohigian G; Gale A; Powell M; Hagan JC Mo Med; 2011; 108(5):320-9. PubMed ID: 22073488 [No Abstract] [Full Text] [Related]
16. Biased articles. Friedman JH Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378 [No Abstract] [Full Text] [Related]
17. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry. Quan SF J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720 [No Abstract] [Full Text] [Related]
18. Supping with the devil? The dangers of liaisons between pharma and our profession. Boyce P; Malhi GS Aust N Z J Psychiatry; 2012 Jun; 46(6):493-4. PubMed ID: 22679200 [No Abstract] [Full Text] [Related]
19. Ball or aerosol? Sin, soap and the pharmaceutical industry. Ratcliff E Australas Psychiatry; 2013 Feb; 21(1):27-31. PubMed ID: 23344801 [TBL] [Abstract][Full Text] [Related]
20. [Clinical practice and pharmaceutical industry: an always difficult relationship]. Mastai R Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851 [No Abstract] [Full Text] [Related] [Next] [New Search]